IMUND

IMUGENE DEF X OPT [IMUND]

1 day chart

About IMUND

Imugene Limited (IMU) is an Australian immuno-oncology focused Biopharmaceutical Company developing range of new and novel immune therapies that seek to activate the immune system of cancer patients to treat and eradicate tumours. The products under development by the group are HER-Vaxx, PD1-Vaxx (formerly KEY-Vaxx), CF-33 and B-Vax.

Buy Australian shares starting with IMUND. Invest today with a CHESS-sponsored investing platform!

Sector

CEO

Mr Charles Walker

Industry

Website

imugene.com

Market Capitalisation

$358M

Price-earnings ratio

Dividend yield

0.00%

High today

Low today

Open price

52-week high

52-week low

Announcements

IMUND FAQs

Can I buy IMUND shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy IMUND shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of IMUGENE DEF X OPT [IMUND]?

One share of IMUGENE DEF X OPT [IMUND] is valued at $0.00.

What is the ticker symbol for IMUGENE DEF X OPT [IMUND]?

The ticker symbol for IMUGENE DEF X OPT [IMUND] is IMUND.

How do I buy IMUND shares in Australia?

To buy IMUND stocks in Australia you'll need to open an account with an investing platform like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake AUS
Deposit directly into your Stake wallet and you're ready to invest in IMUND

What is the 52-week high for IMUGENE DEF X OPT [IMUND] stock?

The IMUGENE DEF X OPT [IMUND] 52-week high stock price is $NaN.

What is the 52-week low for IMUGENE DEF X OPT [IMUND] stock?

The IMUGENE DEF X OPT [IMUND] 52-week low stock price is $NaN.

What is the market capitalisation of IMUGENE DEF X OPT [IMUND] IMUND?

As of 03/10/2023 IMUGENE DEF X OPT [IMUND] has a market cap of $358M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.